Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL5574492 | 0.83 | DNM1 (0.55) | DNM1TSHRAPAF1HSP90AA1RAD52 | |
| Formic Acid SCHEMBL5573574 | 0.82 | MEN1 (0.43) | DNM1CHRM2CHRM1CHRM3TSHR | |
| Formic Acid SCHEMBL556867 | 0.82 | SLC22A1 (0.35) | DNM1CHRM2CHRM1CHRM3TSHR | |
| Formic Acid SCHEMBL5574431 | 0.81 | DNM1 (0.67) | DNM1TSHRAPAF1HSP90AA1RAD52 | |
| SCHEMBL13169630 | 0.80 | — | — | |
| SCHEMBL160184 | 0.80 | — | — | |
| Formic Acid SCHEMBL28452506 | 0.80 | LMNA (0.41) | DNM1CHRM2CHRM1CHRM3TSHR | |
| Formic Acid SCHEMBL5570526 | 0.79 | DNM1 (0.71) | DNM1TSHRAPAF1HSP90AA1RAD52 | |
| Formic Acid SCHEMBL5573542 | 0.79 | DNM1 (0.71) | DNM1TSHRAPAF1HSP90AA1RAD52 | |
| Formic Acid SCHEMBL2533288 | 0.79 | DNM1 (0.71) | DNM1TSHRAPAF1HSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117946019-A | Preparation method of low-color-number low-odor polyisocyanate curing agent | 万华化学集团股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-114945560-A | GPR119 agonists | 卡尔优普公司 | 2022-08-26 | — | — | CN | claimed |
| US-20240115587-A1 | COMBINATION THERAPIES | KALLYOPE, INC. | 2024-04-11 | — | — | US | disclosed |
| WO-2022250012-A1 | CURABLE COMPOSITION, POLYURETHANE RESIN COMPOSITION, AND POLYURETHANE MOLDED BODY | 出光興産株式会社 | 2022-12-01 | — | — | WO | disclosed |
| WO-2012062796-A1 | METHOD FOR MANUFACTURING AN AEROGEL-CONTAINING COMPOSITE AND COMPOSITE PRODUCED BY SAID METHOD | ROCKWOOL INTERNATIONAL A/S (DK) | 2012-05-18 | — | — | WO | disclosed |
| US-20070135565-A1 | COMPOSITION FOR FORMING POROUS FILM, POROUS FILM AND METHOD FOR FORMING THE SAME, INTERLEVEL INSULATOR FILM, AND SEMICONDUCTOR DEVICE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2007-06-14 | — | — | US | disclosed |
| US-7132473-B2 | Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2006-11-07 | — | — | US | disclosed |
| EP-1568744-A1 | COMPOSITION FOR POROUS FILM FORMATION, POROUS FILM, PROCESS FOR PRODUCING THE SAME, INTERLAYER INSULATION FILM AND SEMICONDUCTOR DEVICE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2005-08-31 | — | — | EP | disclosed |
| US-20040219372-A1 | Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115587-A1 | COMBINATION THERAPIES | GPR119, GLP1R, GCGR | DNM1 1110/4885CHRM2 1405/4885CHRM1 1912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.